| 14/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD 4.137(L) | 849,968,000(L) | 28.73 | | 08/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +800,000(L) | HKD 4.358(L) | 848,968,000(L) | 28.70 | | 08/10/2024 | 曲繼廣 | 1113(L) | +800,000(L) | HKD 4.358(L) | 1,135,606,000(L) | 38.39 | | 04/10/2024 | China Pharmaceutical Company Limited | 1710(L) | +300,000(L) | HKD 4.421(L) | 848,168,000(L) | 28.67 | | 04/10/2024 | 曲繼廣 | 1113(L) | +300,000(L) | HKD 4.421(L) | 1,134,806,000(L) | 38.36 | | 25/09/2024 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD 3.832(L) | 1,134,506,000(L) | 38.26 | | 25/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD 3.832(L) | 847,868,000(L) | 28.59 | | 24/09/2024 | 曲繼廣 | 1101(L) | +1,230,000(L) | HKD 3.867(L) | 1,133,506,000(L) | 38.22 | | 23/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +820,000(L) | HKD 3.831(L) | 846,868,000(L) | 28.55 | | 23/09/2024 | 曲繼廣 | 1113(L) | +820,000(L) | HKD 3.831(L) | 1,132,276,000(L) | 38.18 | | 11/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,500,000(L) | HKD 3.799(L) | 846,048,000(L) | 28.50 | | 11/09/2024 | 曲繼廣 | 1113(L) | +2,500,000(L) | HKD 3.799(L) | 1,131,456,000(L) | 38.11 | | 10/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD 3.850(L) | 843,548,000(L) | 28.41 | | 10/09/2024 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD 3.850(L) | 1,128,956,000(L) | 38.02 | | 09/09/2024 | 曲繼廣 | 1113(L) | +1,300,000(L) | HKD 3.848(L) | 1,127,956,000(L) | 37.99 | | 09/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,300,000(L) | HKD 3.848(L) | 842,548,000(L) | 28.38 | | 05/09/2024 | 曲繼廣 | 1113(L) | +2,200,000(L) | HKD 3.908(L) | 1,126,656,000(L) | 37.94 | | 05/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,200,000(L) | HKD 3.908(L) | 841,248,000(L) | 28.33 | | 04/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD 3.906(L) | 839,048,000(L) | 28.26 | | 04/09/2024 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD 3.906(L) | 1,124,456,000(L) | 37.87 | | 03/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD 3.920(L) | 838,048,000(L) | 28.23 | | 03/09/2024 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD 3.920(L) | 1,123,456,000(L) | 37.84 | | 02/09/2024 | 曲繼廣 | 1113(L) | +2,000,000(L) | HKD 3.873(L) | 1,122,056,000(L) | 37.79 | | 02/09/2024 | 曲繼廣 | 1101(L) | +400,000(L) | HKD 3.811(L) | 1,122,456,000(L) | 37.80 | | 02/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,000,000(L) | HKD 3.873(L) | 837,048,000(L) | 28.19 | | 30/08/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,350,000(L) | HKD 3.890(L) | 835,048,000(L) | 28.12 | | 30/08/2024 | 曲繼廣 | 1113(L) | +2,350,000(L) | HKD 3.890(L) | 1,120,056,000(L) | 37.72 | | 21/08/2024 | 四川科倫藥業股份有限公司 | 1101(L) | +5,930,000(L) | HKD 3.536(L) | 628,776,000(L) | 21.18 | | 18/04/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD 4.675(L) | 832,698,000(L) | 28.05 | | 18/04/2024 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD 4.675(L) | 1,117,706,000(L) | 37.65 | | 17/04/2024 | 曲繼廣 | 1113(L) | +800,000(L) | HKD 4.763(L) | 1,116,706,000(L) | 37.61 | | 17/04/2024 | China Pharmaceutical Company Limited | 1101(L) | +800,000(L) | HKD 4.763(L) | 831,698,000(L) | 28.01 | | 05/04/2024 | China Pharmaceutical Company Limited | 1710(L) | +524,000(L) | HKD 4.815(L) | 830,898,000(L) | 27.98 | | 05/04/2024 | 曲繼廣 | 1113(L) | +524,000(L) | HKD 4.815(L) | 1,115,906,000(L) | 37.58 | | 03/04/2024 | 曲繼廣 | 1101(L) | +1,500,000(L) | HKD 5.009(L) | 1,115,382,000(L) | 37.57 | | 02/04/2024 | 曲繼廣 | 1113(L) | +2,000,000(L) | HKD 5.122(L) | 1,113,882,000(L) | 37.52 | | 02/04/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,000,000(L) | HKD 5.122(L) | 830,374,000(L) | 27.97 | | | 1 2 3 4 |
|